Table 2.
Univariate analysis of the relationship between carotid artery plaque and influencing factors.
| Characteristics | No newly developed plaques | Newly developed plaques | p Value |
|---|---|---|---|
| Case, n (%) | 975 (61.7) | 606 (38.3) | |
| Men, n (%) | 291 (29.8) | 266 (43.9) | <0.001 |
| Agea, years | 57.08 ± 7.52 | 60.58 ± 8.05 | <0.001 |
| Age groups, n (%) | <0.001 | ||
| 45–54 | 380 (39) | 139 (22.9) | |
| 55–64 | 424 (43.5) | 285 (47) | |
| ≥65 | 171 (17.5) | 182 (30.0) | |
| BMIa, kg/m2 | 25.77 ± 3.59 | 25.87 ± 3.50 | 0.586 |
| BMI groupsa, n (%) | 0.924 | ||
| Low weight | 8 (0.8) | 4 (0.7) | |
| Normal weight | 297 (30.5) | 182 (30.1) | |
| Overweight | 443 (45.5) | 271 (44.8) | |
| Obesity | 225 (23.1) | 148 (24.5) | |
| Smoke status, n (%) | <0.001 | ||
| Never smoking | 701 (72.3) | 362 (59.8) | |
| Current smoking | 151 (15.6) | 122 (20.2) | |
| Ever smoking | 117 (12.1) | 121 (20.0) | |
| Alcohol consumption, n (%) | <0.001 | ||
| Never drinking | 729 (74.9) | 392 (64.7) | |
| Current drinking | 183 (18.8) | 144 (23.8) | |
| Ever drinking | 61 (6.3) | 70 (11.6) | |
| Hypertension, n (%) | <0.001 | ||
| No | 350 (35.9) | 129 (21.3) | |
| Yes | 625 (64.1) | 477 (78.7) | |
| Diabetes, n (%) | <0.001 | ||
| No | 831 (85.2) | 458 (75.6) | |
| Yes | 144 (14.8) | 148 (24.4) | |
| SBPa, mmHg | 141.62 ± 20.20 | 148.12 ± 19.92 | <0.001 |
| DBPa, mmHg | 86.22 ± 11.36 | 87.78 ± 10.89 | 0.007 |
| FPGa, mmol/L | 5.72 ± 1.25 | 6.02 ± 1.44 | <0.001 |
| TCa, mmol/L | 4.78 ± 1.00 | 4.81 ± 0.97 | 0.518 |
| TGa, mmol/L | 1.64 ± 1.24 | 1.68 ± 1.19 | 0.484 |
| HDL-Ca, mmol/L | 1.49 ± 0.45 | 1.39 ± 0.38 | <0.001 |
| LDL-Ca, mmol/L | 2.56 ± 0.86 | 2.66 ± 0.83 | 0.024 |
| LHRa | 1.84 ± 0.76 | 2.03 ± 0.77 | <0.001 |
| TyG | 8.70 ± 0.59 | 8.81 ± 0.61 | 0.034 |
Continuous variables were expressed as mean ± standard deviation. BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; FPG, fasting plasma glucose; TC, total cholesterol; TG, triglycerides; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; LHR, LDL-C/HDL-C ratio.